Skip to main content
  • About
  • Research Projects
  • Methods Research
  • Education
  • Careers
  • People
Body
Home
Body
  •  
  •  
  •  
Menu

Main navigation

  • About
    • Mission and Vision
    • History
    • 50th Anniversary
    • COVID Safety Protocol
    • News
    • Professional Service
    • Publications
  • Research Projects
  • Methods Research
    • Programs, Data and Materials
  • Education
    • Materials
  • Careers
  • People
    • Faculty
    • Research Investigators
    • Admin Leadership
    • Alumni
    • Directors
Submitted by janeu on Fri, 07/22/2022 - 12:58
enicto
Exercise And Nutrition Interventions To Improve Cancer Treatment-Related Outcomes (ENICTO)

The research objectives of the ENICTO Consortium are to support the development and testing of exercise and/or medical nutrition interventions designed to improve cancer treatment-related outcomes for therapies delivered with curative or life-extending intent to cancer survivors, defined as individuals from the day of diagnosis until the end of life. The ENICTO Consortium is comprised of four randomized clinical trials with common research goals.
1)    Dose-response of aerobic training during total neo- adjuvant therapy for locally advanced rectal cancer (TNT) (Sloan-Kettering/NYC).
2)    Trial of exercise and lifestyle (TEAL) in women with ovarian cancer (Yale/New Haven, U Miami)
3)    Aerobic exercise during chemotherapy in colon cancer (Pennington/Baton Rouge, Dana Farber/Boston, Kaiser/Oakland)
4)    Tele-health resistance exercise intervention to preserve dose intensity and vitality in elder breast cancer patients (THRIVE-65) (Penn State/Hershey, Dana Farber/Boston, Case Western/Cleveland)

VISIT STUDY WEBSITE

PRINCIPAL INVESTIGATOR(S)

Scott Evans, PhD

Kim Robien, PhD

ADDITIONAL INVESTIGATOR(S)

Sharon Edelstein, ScM

RESEARCH STAFF

Ashley Hogan Tjaden, MPH

MAJOR PUBLICATIONS

Coming soon

Project Overview:

The Consortium supports exercise and/or medical nutrition intervention research designed to improve cancer treatment-related outcomes for therapies delivered with curative or life-extending intent to cancer survivors.

Funding Agency or Sponsor:

NCI

MORE ›
Body

  Rockville, MD 20852-3943
6110 Executive Boulevard
Suite 750

 (301) 881-9260
 info@bsc.gwu.edu

Useful Links

GW Milken Institute School of Public Health
GW Department of Epidemiology
GW Department of Biostatistics and Bioinformatics
Careers at BSC
News
Body
Body
Body
Body